Tysabri (natalizumab) approved for MS
- Details
- Category: Medications
- Written by R. Adam Quigley
- Hits: 1310
* antibody that makes it difficult for immune system cells to
move into the brain and spinal cord
* for relapsing remitting MS that has not responded
to other treatment
* reduces relapse rate
* IV infusion once every four weeks
* 1/3 of patients improve in disability, suppresses 90% of MRI disease
* increases risk (1:1000) of viral infection of the brain
* infrequent side effects: headache, pain, fatigue, diarrhea, depression
* approved in 2006



Ultrahigh-field strength, T1-weighted magnetization-prepared rapid acquisition and multiple gradient echoes (MPRAGE) is highly sensitive for detecting multiple sclerosis (MS) plaques within the white and gray brain parenchyma, according to a study published online Feb. 20 in Archives of Neurology, one of the JAMA/Archives...
Cannabis-based medicinal products, such as Sativex, could soon be available to sufferers of Multiple Sclerosis (MS) and other medical conditions on prescription.
One in a lakh Indians is thought to suffer from multiple sclerosis, a life-long disorder of the nervous system. Support groups are lobbying to bring the disease under the Disability Act, and are fighting for insurance cover.



